Wenjie Zhang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Municipal Solid Waste

Multiple Myeloma

Chronic Lymphocytic Leukemia

Mesenchymal Stem Cells

Top Venues

Experimental hematology & oncology

Biomarker research

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Wenjie Zhang, Sumei Li, Jinlan Long, Shufeng Xie, Minghui Wang, Han Liu, Zhen-Shu Xu
Novel CAR T-cell therapies for relapsed/refractory B-cell malignancies: latest updates from 2023 ASH annual meeting. Experimental hematology & oncology 13 (1) (2024)
Wenjie Zhang, Sumei Li, Jinlan Long, Shufeng Xie, Minghui Wang, Han Liu, Zhen-Shu Xu
Novel CAR T-cell therapies for relapsed/refractory B-cell malignancies: latest updates from 2023 ASH annual meeting. Experimental hematology & oncology 13 (1) (2024)
Wenjie Zhang, Sumei Li, Jinlan Long, Shufeng Xie, Minghui Wang, Han Liu, Zhen-Shu Xu
Novel CAR T-cell therapies for relapsed/refractory B-cell malignancies: latest updates from 2023 ASH annual meeting. Experimental hematology & oncology 13 (1) (2024)
Wenjie Zhang, Sumei Li, Chufeng Zhang, Zhengshuai Mu, Kaili Chen, Zhen-Shu Xu
Tumor-infiltrating lymphocytes predict efficacy of immunotherapy in advanced non-small cell lung cancer: a single-center retrospective cohort study. Acta oncologica (Stockholm, Sweden) (2023)
Wenjie Zhang, Jinlan Long, Peixia Tang, Kaili Chen, Guangyao Guo, Zezhong Yu, Jie Lin, Liping Liu, Rong Zhan, Zhen-Shu Xu
SYT7 regulates the progression of chronic lymphocytic leukemia through interacting and regulating KNTC1. Biomarker research 11 (1) (2023)